T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 3,931 | 2,311 | 1,661 | 1,108 | 956 |
| Cost of Goods | 3,458 | 3,273 | 6,306 | 2,106 | 1,989 |
| Gross Profit | 473 | -962 | -4,645 | -998 | -1,033 |
| Operating Expenses | 11,818 | 10,746 | 10,027 | 11,545 | 13,860 |
| Operating Income | -10,887 | -11,435 | -14,366 | -12,437 | -13,904 |
| Interest Expense | 1,506 | 1,568 | 3,898 | 1,718 | 1,654 |
| Other Income | 69 | 90 | 71 | 79 | 102 |
| Pre-tax Income | -12,324 | -12,913 | -18,193 | -14,076 | -15,456 |
| Net Income Continuous | -12,324 | -12,913 | -18,193 | -14,076 | -15,456 |
| Net Income | $-12,324 | $-12,913 | $-18,193 | $-14,076 | $-15,456 |
| EPS Basic Total Ops | -1,600.00 | -1,800.00 | -2,550.00 | -2,250.00 | -2,500.00 |
| EPS Basic Continuous Ops | -1,610.43 | -1,794.57 | -2,546.07 | -2,239.90 | -2,520.47 |
| EPS Diluted Total Ops | -1,600.00 | -1,800.00 | -2,550.00 | -2,250.00 | -2,500.00 |
| EPS Diluted Continuous Ops | -1,610.43 | -1,794.57 | -2,546.07 | -2,239.90 | -2,520.47 |
| EBITDA(a) | $-10,292 | $-10,806 | $-13,620 | $-11,675 | $-13,166 |